말초혈 단핵세포(PBMC) 시장

The global market for peripheral blood mononuclear cells (PBMCs) was valued at $322.2 million in 2025 and, is estimated to reach $353.9 million by 2026 and $577.2 million by 2031, at a compound annual growth rate (CAGR) of 10.3% from 2026 through 2031.

Report Scope

The report provides an overview of the global peripheral blood mononuclear cells (PBMCs) market and analyzes market trends. It includes global revenue ($ Thousand) using 2025 as the base year, estimated data for 2026, and projected data for 2026 through 2031.

The report segments the market by product type, application, and technology. By product type, the market is segmented into cryopreserved or frozen PBMCs, peripheral blood mononuclear cell isolation and viability kits, cultured or fresh PBMCs, and others. Based on application, the market is categorized into oncology, immunology, vaccine development, toxicology, infectious disease, and others. By technology, the market is segmented into density gradient centrifugation, leukapheresis, and others. Geographical regions covered in this study include North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), South America, and the Middle East and Africa (MEA) with a focus on the major countries in these regions.

The report focuses on the key drivers, trends, and challenges shaping the market and vendor landscape. It analyzes and discusses emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape and highlights the leading global peripheral blood mononuclear cell companies. It also includes a dedicated section of company profiles covering company overviews, key financials, product portfolios, and recent developments.

Report Includes

• 40 data tables and 54 additional tables
• Examination of the global peripheral blood mononuclear cells (PBMCs) market, covering research applications, technological developments, and the growing role of immune cell analysis in life sciences and clinical research
• Market estimates based on 2025 data, with revenue forecasts and growth projections for the period from 2026 through 2031
• Analysis of market segments by product type, application, and isolation technique,
• Discussion of key market drivers, restraints, opportunities, and challenges influencing industry growth and adoption patterns
• Regional evaluation of North America, Europe, Asia-Pacific, South America, and the Middle East & Africa, including country-level analysis of major research and healthcare markets
• Competitive landscape assessment featuring company rankings, market share analysis, and strategic initiatives undertaken by leading market participants
• Profiles of established companies and emerging players involved in the PBMC market, highlighting their product offerings, business strategies, and recent developments
• Company profiles of major players within the industry, including BioIVT, CGT Global, Charles River Laboratories, Discovery Life Sciences, Lonza, and STEMCELL Technologies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Technological Advances
• Conclusion

Chapter 2 Market Overview

• Overview
• Source of PBMCs
• Method of PBMC Isolation
• Freezing and Thawing of PBMCs
• Applications for PBMCs
• Macroeconomic Factor Analysis
• Healthcare and Life Sciences R&D Expenditure
• Impact of the Israel-U.S. and Iran war
• Porter's Five Forces Analysis in the Peripheral Blood Mononuclear Cells Market
• Potential for New Entrants (Moderate)
• Bargaining Power of Suppliers (High)
• Bargaining Power of Buyers (Moderate)
• Threat of Substitutes (Moderate to High)
• Competition in the Industry (High)

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Immunology and Vaccine Research Demand
• Growing Cell and Gene Therapy Development
• Increasing Use of PBMCs in Biomarkers and Infectious Diseases
• Market Restraints
• High PBMC Processing and Storage Costs
• Sample Variability and Viability Issues
• Market Opportunities
• Expansion of Precision Medicine and Biobanking
• Emerging Markets
• Market Challenges
• Cold-Chain and Logistics Complexity
• Ethical and Regulatory Concerns

Chapter 4 Regulatory Landscape

• U.S.
• Europe
• Other Regions

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• Automated PBMC Isolation Systems
• Advanced Cryopreservation and DMSO-Free Technologies
• Artificial Intelligence
• Clinical Trials Analysis
• Key Takeaways
• Clinical Trials Analysis, by Type of Study
• Clinical Trials Analysis, by Status
• Clinical Trials Analysis, by Phase
• Patent Analysis
• Key Takeaways
• Patents, by Year
• By Top Applicant
• By Top Owner
• By Jurisdiction

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• Cryopreserved or Frozen PBMC
• Peripheral Blood Mononuclear Cell Isolation and Viability Kits
• Cultured or Fresh PBMC
• Others
• Market Analysis by Technology
• Key Takeaways
• Density Gradient Centrifugation
• Leukapheresis
• Other Technologies
• Market Analysis by Application
• Key Takeaways
• Oncology
• Immunology
• Infectious Disease
• Vaccine Development
• Toxicology
• Other Applications
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Leading Companies of the PBMC Market
• Key Developments and Strategies

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AKADEUM LIFE SCIENCES
• ATCC
• BIOIVT
• BIOLEGEND INC.
• CGT GLOBAL
• CHARLES RIVER LABORATORIES
• CYTIVA
• DISCOVERY LIFE SCIENCES
• IXCELLS BIOTECHNOLOGIES
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PRECISION MEDICINE GROUP LLC
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.
• Emerging Start-ups/ Market Disruptors